Raymund R. Razonable

18.0k total citations · 3 hit papers
290 papers, 11.1k citations indexed

About

Raymund R. Razonable is a scholar working on Epidemiology, Infectious Diseases and Oncology. According to data from OpenAlex, Raymund R. Razonable has authored 290 papers receiving a total of 11.1k indexed citations (citations by other indexed papers that have themselves been cited), including 200 papers in Epidemiology, 138 papers in Infectious Diseases and 51 papers in Oncology. Recurrent topics in Raymund R. Razonable's work include Cytomegalovirus and herpesvirus research (133 papers), Herpesvirus Infections and Treatments (91 papers) and COVID-19 Clinical Research Studies (41 papers). Raymund R. Razonable is often cited by papers focused on Cytomegalovirus and herpesvirus research (133 papers), Herpesvirus Infections and Treatments (91 papers) and COVID-19 Clinical Research Studies (41 papers). Raymund R. Razonable collaborates with scholars based in United States, Philippines and Canada. Raymund R. Razonable's co-authors include Atul Humar, Carlos V. Payá, Robert A. Brown, Albert Eid, Walter K. Kremers, A.J. Eid, Poornima Ramanan, Robin Patel, Paul J. Deziel and Elena Beam and has published in prestigious journals such as JAMA, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Raymund R. Razonable

281 papers receiving 10.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials: Table 1.

2016 693 citations Michael Boeckh, Raymund R. Razonable et al. Clinical Infectious Diseases profile →
Cytomegalovirus in solid organ transplant recipients—Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice

2019 471 citations Raymund R. Razonable et al. Clinical Transplantation profile →
Cytomegalovirus in Solid Organ Transplantation

2013 389 citations Raymund R. Razonable et al. American Journal of Transplantation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Raymund R. Razonable United States	58	8.1k	3.8k	2.3k	1.5k	980	290	11.1k
Atul Humar Canada	67	10.6k 1.3×	4.1k 1.1×	2.9k 1.3×	2.2k 1.4×	1.6k 1.6×	275	14.4k
Deepali Kumar Canada	56	6.8k 0.8×	3.8k 1.0×	1.5k 0.7×	1.6k 1.1×	1.2k 1.2×	233	10.0k
Ajit P. Limaye United States	55	5.5k 0.7×	3.1k 0.8×	2.7k 1.2×	793 0.5×	846 0.9×	182	9.3k
Robin K. Avery United States	53	6.0k 0.7×	4.7k 1.2×	1.8k 0.8×	1.8k 1.1×	1.2k 1.2×	226	10.6k
Francisco M. Marty United States	52	4.8k 0.6×	3.5k 0.9×	1.5k 0.7×	784 0.5×	758 0.8×	204	8.2k
José María Aguado Spain	48	4.4k 0.5×	3.5k 0.9×	831 0.4×	1.9k 1.2×	764 0.8×	298	7.9k
Emily A. Blumberg United States	44	4.5k 0.6×	2.0k 0.5×	983 0.4×	1.3k 0.9×	1.6k 1.7×	185	7.0k
Michael G. Ison United States	51	5.7k 0.7×	2.9k 0.8×	906 0.4×	1.2k 0.8×	920 0.9×	234	8.5k
Asunción Moreno Spain	51	5.6k 0.7×	3.9k 1.0×	550 0.2×	1.3k 0.8×	951 1.0×	257	8.2k
Shahid Husain Canada	54	6.6k 0.8×	5.2k 1.4×	1.1k 0.5×	2.3k 1.5×	818 0.8×	250	10.4k

Countries citing papers authored by Raymund R. Razonable

Since Specialization

Citations

This map shows the geographic impact of Raymund R. Razonable's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raymund R. Razonable with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raymund R. Razonable more than expected).

Fields of papers citing papers by Raymund R. Razonable

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raymund R. Razonable. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raymund R. Razonable. The network helps show where Raymund R. Razonable may publish in the future.

Co-authorship network of co-authors of Raymund R. Razonable

This figure shows the co-authorship network connecting the top 25 collaborators of Raymund R. Razonable. A scholar is included among the top collaborators of Raymund R. Razonable based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raymund R. Razonable. Raymund R. Razonable is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bell, Christopher F., Daniel C. Gibbons, Vishal Patel, et al.. (2024). Real-world effectiveness of sotrovimab in preventing hospitalization and mortality in high-risk patients with COVID-19 in the United States: A cohort study from the Mayo Clinic electronic health records. PLoS ONE. 19(7). e0304822–e0304822. 4 indexed citations

Suarez, Maria Lourdes Gonzalez, et al.. (2024). Association of renal function with mortality among hospitalized patients treated with remdesivir for COVID-19. PLoS ONE. 19(6). e0303896–e0303896. 1 indexed citations

Zamora, Danniel, Sayan Dasgupta, Terry Stevens‐Ayers, et al.. (2024). Cytomegalovirus immunity in high-risk liver transplant recipients following preemptive antiviral therapy versus prophylaxis. JCI Insight. 9(18). 3 indexed citations

Girardo, Marlene, et al.. (2024). Brain abscess following solid organ transplantation: A 21‐year retrospective study. Transplant Infectious Disease. 26(6). e14394–e14394. 2 indexed citations

Friedman, Daniel, Elitza S. Theel, Randall C. Walker, et al.. (2024). Serial Bronchoalveolar Lavage Fluid Aspergillus Galactomannan and Treatment Response in Invasive Pulmonary Aspergillosis. Open Forum Infectious Diseases. 11(4). ofae114–ofae114. 2 indexed citations

Vergidis, Paschalis, et al.. (2023). Genotypic and predicted phenotypic analysis of SARS-COV-2 Omicron subvariants in immunocompromised patients with COVID-19 following tixagevimab-cilgavimab prophylaxis. Journal of Clinical Virology. 160. 105382–105382. 9 indexed citations

Razonable, Raymund R.. (2023). Oral antiviral drugs for treatment of cytomegalovirus in transplant recipients. Clinical Microbiology and Infection. 29(9). 1144–1149. 18 indexed citations

Yetmar, Zachary A., Yogish C. Kudva, Maria Teresa Seville, et al.. (2023). Risk of cytomegalovirus infection and subsequent allograft failure after pancreas transplantation. American Journal of Transplantation. 24(2). 271–279. 3 indexed citations

Mendoza, Maria A., Nischal Ranganath, Supavit Chesdachai, et al.. (2023). Immunomodulators for severe coronavirus disease‐2019 in transplant patients: Do they increase the risk of secondary infection?. Transplant Infectious Disease. 25(2). e14050–e14050. 2 indexed citations

10.

Ranganath, Nischal, John C. O’Horo, Douglas W. Challener, et al.. (2022). Rebound Phenomenon After Nirmatrelvir/Ritonavir Treatment of Coronavirus Disease 2019 (COVID-19) in High-Risk Persons. Clinical Infectious Diseases. 76(3). e537–e539. 45 indexed citations

11.

Ripoll, Juan G., Justin E. Juskewitch, Raymund R. Razonable, et al.. (2022). Vaccine-boosted convalescent plasma therapy for patients with immunosuppression and COVID-19. Blood Advances. 6(23). 5951–5955. 12 indexed citations

12.

Bierle, Dennis M., Ravindra Ganesh, Sidna M. Tulledge‐Scheitel, et al.. (2021). Monoclonal Antibody Treatment of Breakthrough COVID-19 in Fully Vaccinated Individuals with High-Risk Comorbidities. The Journal of Infectious Diseases. 225(4). 598–602. 31 indexed citations

13.

Benson, Constance A., Brian G. Blackburn, Vera Luther, et al.. (2021). Virtual Recruitment Is Here to Stay: A Survey of ID Fellowship Program Directors and Matched Applicants Regarding Their 2020 Virtual Recruitment Experiences. Open Forum Infectious Diseases. 8(8). ofab383–ofab383. 15 indexed citations

14.

Razonable, Raymund R.. (2018). Drug-resistant cytomegalovirus: clinical implications of specific mutations. Current Opinion in Organ Transplantation. 23(4). 388–394. 55 indexed citations

15.

Razonable, Raymund R., et al.. (2018). Pharmacologic and immunologic management of cytomegalovirus infection after solid organ and hematopoietic stem cell transplantation. Expert Review of Clinical Pharmacology. 11(8). 773–788. 17 indexed citations

16.

Vergidis, Paschalis, Raymund R. Razonable, L. Joseph Wheat, et al.. (2014). Reduction in False-Positive Aspergillus Serum Galactomannan Enzyme Immunoassay Results Associated with Use of Piperacillin-Tazobactam in the United States. Journal of Clinical Microbiology. 52(6). 2199–2201. 46 indexed citations

17.

Kang, Seung Hee, Rima Abdel-Massih, Robert A. Brown, et al.. (2012). Homozygosity for the Toll-Like Receptor 2 R753Q Single-Nucleotide Polymorphism Is a Risk Factor for Cytomegalovirus Disease After Liver Transplantation. The Journal of Infectious Diseases. 205(4). 639–646. 55 indexed citations

18.

Romero, Fabián Andrés Rosas, Paul J. Deziel, & Raymund R. Razonable. (2011). Majocchi's granuloma in solid organ transplant recipients. Transplant Infectious Disease. 13(4). 424–432. 23 indexed citations

19.

Eid, Albert, Rachel Pedersen, Ross Dierkhising, et al.. (2007). Delayed-Onset Primary Cytomegalovirus Disease After Liver Transplantation. Liver Transplantation. 13(12). 1703–1709. 90 indexed citations

20.

Assi, Maha, José S. Pulido, Steve G. Peters, Colin A. McCannel, & Raymund R. Razonable. (2006). Graft‐vs.‐host disease in lung and other solid organ transplant recipients. Clinical Transplantation. 21(1). 1–6. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact